Back to 
Point72 Asset Management, L.P.
Point72 Asset Management, L.P.
IMVT
Showing 5 of 22 quarters
Position history for Point72 Asset Management, L.P.'s holdings in Immunovant, Inc.
No. Point72 Asset Management exited its IMVT (Immunovant) position in Q1 2026. Its Q4 2025 13F listed 2,000,000 shares worth $50.8M. Point72 Asset Management first reported IMVT in Q1 2020 and held it in 16 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$13.7M
Total Shares Change
-801,927
Quarter-by-Quarter History